These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 1937192)

  • 1. [Sustained release verapamil in essential hypertension].
    Yodfat Y; Nusbaum M; Gibor Y
    Harefuah; 1991 May; 120(10):581-4. PubMed ID: 1937192
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Controlled study on the treatment of hypertension with verapamil in retard form].
    Belz GG; Spies G
    Z Kardiol; 1985 Aug; 74(8):453-9. PubMed ID: 3901562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of nonsteroidal anti-inflammatory drugs on blood pressures of patients with hypertension controlled by verapamil.
    Houston MC; Weir M; Gray J; Ginsberg D; Szeto C; Kaihlenen PM; Sugimoto D; Runde M; Lefkowitz M
    Arch Intern Med; 1995 May; 155(10):1049-54. PubMed ID: 7748048
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conversion from sustained-release to immediate-release calcium entry blockers: outcome in patients with mild-to-moderate hypertension.
    Hilleman DE; Mohiuddin SM; Lucas BD; Shinn B; Elsasser GN
    Clin Ther; 1993; 15(6):1002-10. PubMed ID: 8111798
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and tolerability of extended-release felodipine and extended-release nifedipine in patients with mild-to-moderate essential hypertension.
    Fagan TC; Haggert BE; Liss C
    Clin Ther; 1994; 16(4):634-46. PubMed ID: 7982251
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and tolerability of enalapril and sustained-release verapamil in older patients with mild to moderate essential hypertension.
    Weir MR; Cassidy CA; Hall PS; Lancaster A; Schubert C; Urick A; Saunders E; Kong BW; Jenkins P; Lavin PT
    Clin Ther; 1990; 12(2):139-48. PubMed ID: 2354483
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The TEAM study--a study of the effectiveness and tolerance of treatment of essential hypertension with a fixed combination of trandolapril and verapamil].
    Widimský J; Dzúrik R
    Vnitr Lek; 1998 Jun; 44(6):326-31. PubMed ID: 9820054
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nifedipine and atenolol singly and combined for treatment of essential hypertension: comparative multicentre study in general practice in the United Kingdom. Nifedipine-Atenolol Study Review Committee.
    Nifedipine-Atenolol Study Review Committee
    Br Med J (Clin Res Ed); 1988 Feb; 296(6620):468-72. PubMed ID: 2894883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A 26-week, prospective, open-label, uncontrolled, multicenter study to evaluate the effect of an escalating-dose regimen of trandolapril on change in blood pressure in treatment-naive and concurrently treated adult hypertensive subjects (TRAIL).
    Tytus RH; Burgess ED; Assouline L; Vanjaka A
    Clin Ther; 2007 Feb; 29(2):305-15. PubMed ID: 17472822
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety of controlled-onset extended-release verapamil in middle-aged and older patients with hypertension and coronary artery disease.
    White WB; Johnson MF; Anders RJ; Elliott WJ; Black HR
    Am Heart J; 2001 Dec; 142(6):1010-5. PubMed ID: 11717605
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of sustained-release verapamil: automatic ambulatory blood pressure monitoring.
    Zachariah PK; Sheps SG; Schriger A
    J Clin Hypertens; 1986 Sep; 2(3 Suppl):133S-142S. PubMed ID: 3540223
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prazosin GITS vs sustained release nifedipine in patients with hypertension and abnormal lipid profile: a randomized, controlled, multicenter study. Madras Hypertension Study Group.
    Misra KP; Joglekar SJ; Mukherjee S; Nanivadekar AS
    J Assoc Physicians India; 1998; Suppl 1():30-40. PubMed ID: 11233385
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term safety and efficacy comparison of immediate-release and sustained-release oral verapamil in systemic hypertension.
    Frishman WH; Eisen G; Charlap S; Strom JA
    J Clin Hypertens; 1987 Dec; 3(4):605-9. PubMed ID: 3134517
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new sustained-release formulation of verapamil in the treatment of hypertension.
    Midtbo KA; Hals O; Lauve O
    J Clin Hypertens; 1986 Sep; 2(3 Suppl):125S-132S. PubMed ID: 3540222
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The combination of verapamil and captopril in the treatment of essential hypertension.
    Heagerty AM; Swales JD
    Pharmatherapeutica; 1987; 5(1):21-5. PubMed ID: 3299395
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Evaluation of the antihypertensive efficacy and safety of using sustained release verapamil in elderly subjects using ambulatory blood pressure monitoring].
    Jasiński T; Janicki K; Klima M; Pieniazek W; Bednarz S
    Przegl Lek; 1996; 53(2):73-7. PubMed ID: 8754325
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of long-acting propranolol and verapamil on blood pressure, platelet function, metabolic and rheological properties in hypertension.
    Ding YA; Chou TC; Lin KC
    J Hum Hypertens; 1994 Apr; 8(4):273-8. PubMed ID: 8021907
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antihypertensive efficacy of sustained-release verapamil.
    Zachariah PK; Sheps SG; Oshrain C; Schirger A; Stein WJ
    J Clin Hypertens; 1987 Dec; 3(4):536-46. PubMed ID: 3330987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A comparison of the effects of verapamil and nifedipine on the quality of life].
    Palmer A; Fletcher A; Hamilton G; Muriss S; Bulpitt C
    Wien Med Wochenschr; 1991; 141(18-19):424-8. PubMed ID: 1776257
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of mild-to-moderate hypertension with calcium channel blockers: a multicentre comparison of once-daily nifedipine GITS with once-daily amlodipine.
    Kes S; Caglar N; Canberk A; Deger N; Demirtas M; Dortlemez H; Kiliccioglu B; Kozan O; Ovunc K; Turkoglu C
    Curr Med Res Opin; 2003; 19(3):226-37. PubMed ID: 12803737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.